Coronary artery disease (CAD) is a pathological process characterized by atherosclerotic plaque accumulation in the epicardial arteries, whether obstructive or non-obstructive. This process can be modified by lifestyle adjustments, pharmacological therapies, and invasive interventions designed to achieve disease stabilization or regression. The disease can have long, stable periods but can also become unstable at any time, typically due to an acute atherothrombotic event caused by plaque rupture or erosion. However, the disease is chronic, most often progressive, and hence serious, even in clinically apparently silent periods. The dynamic nature of the CAD process results in various clinical presentations, which can be conveniently categorized as either acute coronary syndromes (ACS) or chronic coronary syndromes (CCS). The Guidelines presented here refer to the management of patients with CCS

2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes / Knuuti, J.; Wijns, W.; Achenbach, S.; Agewall, S.; Barbato, E.; Bax, J. J.; Capodanno, D.; Cuisset, T.; Deaton, C.; Dickstein, K.; Edvardsen, T.; Escaned, J.; Funck-Brentano, C.; Gersh, B. J.; Gilard, M.; Hasdai, D.; Hatala, R.; Mahfoud, F.; Masip, J.; Muneretto, C.; Prescott, E.; Saraste, A.; Storey, R. F.; Svitil, P.; Valgimigli, M.; Windecker, S.; Aboyans, V.; Baigent, C.; Collet, J. -P.; Dean, V.; Delgado, V.; Fitzsimons, D.; Gale, C. P.; Grobbee, D. E.; Halvorsen, S.; Hindricks, G.; Iung, B.; Juni, P.; Katus, H. A.; Landmesser, U.; Leclercq, C.; Lettino, M.; Lewis, B. S.; Merkely, B.; Mueller, C.; Petersen, S.; Petronio, A. S.; Richter, D. J.; Roffi, M.; Shlyakhto, E.; Simpson, I. A.; Sousa-Uva, M.; Touyz, R. M.; Benkhedda, S.; Metzler, B.; Sujayeva, V.; Cosyns, B.; Kusljugic, Z.; Velchev, V.; Panayi, G.; Kala, P.; Haahr-Pedersen, S. A.; Kabil, H.; Ainla, T.; Kaukonen, T.; Cayla, G.; Pagava, Z.; Woehrle, J.; Kanakakis, J.; Toth, K.; Gudnason, T.; Peace, A.; Aronson, D.; Riccio, C.; Elezi, S.; Mirrakhimov, E.; Hansone, S.; Sarkis, A.; Babarskiene, R.; Beissel, J.; Cassar Maempel, A. J.; Revenco, V.; de Grooth, G. J.; Pejkov, H.; Juliebo, V.; Lipiec, P.; Santos, J.; Chioncel, O.; Duplyakov, D.; Bertelli, L.; Dikic, A. D.; Studencan, M.; Bunc, M.; Alfonso, F.; Back, M.; Zellweger, M.; Addad, F.; Yildirir, A.; Sirenko, Y.; Clapp, B.. - In: EUROPEAN HEART JOURNAL. - ISSN 0195-668X. - 41:3(2020), pp. 407-477. [10.1093/eurheartj/ehz425]

2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes

Barbato E.;
2020

Abstract

Coronary artery disease (CAD) is a pathological process characterized by atherosclerotic plaque accumulation in the epicardial arteries, whether obstructive or non-obstructive. This process can be modified by lifestyle adjustments, pharmacological therapies, and invasive interventions designed to achieve disease stabilization or regression. The disease can have long, stable periods but can also become unstable at any time, typically due to an acute atherothrombotic event caused by plaque rupture or erosion. However, the disease is chronic, most often progressive, and hence serious, even in clinically apparently silent periods. The dynamic nature of the CAD process results in various clinical presentations, which can be conveniently categorized as either acute coronary syndromes (ACS) or chronic coronary syndromes (CCS). The Guidelines presented here refer to the management of patients with CCS
2020
Angina pectoris; anti-ischaemic drugs; antithrombotic therapy; chronic coronary syndromes; coronary artery disease; diagnostic testing; guidelines; imaging; lifestyle modifications; lipid-lowering drugs; microvascular angina; myocardial ischaemia; myocardial revascularization; risk assessment; screening; vasospastic angina
01 Pubblicazione su rivista::01a Articolo in rivista
2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes / Knuuti, J.; Wijns, W.; Achenbach, S.; Agewall, S.; Barbato, E.; Bax, J. J.; Capodanno, D.; Cuisset, T.; Deaton, C.; Dickstein, K.; Edvardsen, T.; Escaned, J.; Funck-Brentano, C.; Gersh, B. J.; Gilard, M.; Hasdai, D.; Hatala, R.; Mahfoud, F.; Masip, J.; Muneretto, C.; Prescott, E.; Saraste, A.; Storey, R. F.; Svitil, P.; Valgimigli, M.; Windecker, S.; Aboyans, V.; Baigent, C.; Collet, J. -P.; Dean, V.; Delgado, V.; Fitzsimons, D.; Gale, C. P.; Grobbee, D. E.; Halvorsen, S.; Hindricks, G.; Iung, B.; Juni, P.; Katus, H. A.; Landmesser, U.; Leclercq, C.; Lettino, M.; Lewis, B. S.; Merkely, B.; Mueller, C.; Petersen, S.; Petronio, A. S.; Richter, D. J.; Roffi, M.; Shlyakhto, E.; Simpson, I. A.; Sousa-Uva, M.; Touyz, R. M.; Benkhedda, S.; Metzler, B.; Sujayeva, V.; Cosyns, B.; Kusljugic, Z.; Velchev, V.; Panayi, G.; Kala, P.; Haahr-Pedersen, S. A.; Kabil, H.; Ainla, T.; Kaukonen, T.; Cayla, G.; Pagava, Z.; Woehrle, J.; Kanakakis, J.; Toth, K.; Gudnason, T.; Peace, A.; Aronson, D.; Riccio, C.; Elezi, S.; Mirrakhimov, E.; Hansone, S.; Sarkis, A.; Babarskiene, R.; Beissel, J.; Cassar Maempel, A. J.; Revenco, V.; de Grooth, G. J.; Pejkov, H.; Juliebo, V.; Lipiec, P.; Santos, J.; Chioncel, O.; Duplyakov, D.; Bertelli, L.; Dikic, A. D.; Studencan, M.; Bunc, M.; Alfonso, F.; Back, M.; Zellweger, M.; Addad, F.; Yildirir, A.; Sirenko, Y.; Clapp, B.. - In: EUROPEAN HEART JOURNAL. - ISSN 0195-668X. - 41:3(2020), pp. 407-477. [10.1093/eurheartj/ehz425]
File allegati a questo prodotto
File Dimensione Formato  
Knuuti_2019-ESC-Guidelines_2020.pdf

solo gestori archivio

Tipologia: Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 2.51 MB
Formato Adobe PDF
2.51 MB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1660432
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5034
  • ???jsp.display-item.citation.isi??? 4565
social impact